BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 11007917)

  • 21. Treatment of human bone marrow with recombinant placenta immunoregulator ferritin results in myelopoiesis and T-cell suppression through modulation of the cytokine-chemokine networks.
    Moroz C; Grunspan A; Zahalka MA; Traub L; Kodman Y; Yaniv I
    Exp Hematol; 2006 Feb; 34(2):159-66. PubMed ID: 16459184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cAMP analogues downregulate the expression of granulocyte macrophage colony-stimulating factor (GM-CSF) in human bone marrow stromal cells in vitro.
    Bug G; Aman J; Huber C; Peschel C; Derigs HG
    Mediators Inflamm; 1998; 7(3):195-9. PubMed ID: 9705607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cytokines and growth factors on the macrophage colony-stimulating factor secretion by human bone marrow stromal cells.
    Besse A; Trimoreau F; Praloran V; Denizot Y
    Cytokine; 2000 May; 12(5):522-5. PubMed ID: 10857771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia.
    Tennant GB; Walsh V; Truran LN; Edwards P; Mills KI; Burnett AK
    Br J Haematol; 2000 Dec; 111(3):853-62. PubMed ID: 11122147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells.
    Roman-Unfer S; Bitran JD; Garrison L; Proeschel C; Hanauer S; Schroeder L; Johnson L; Klein L; Martinec J
    Exp Hematol; 1996 Jun; 24(7):823-8. PubMed ID: 8647233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PIXY321 (GM-CSF/IL-3 fusion protein): biology and early clinical development.
    Vadhan-Raj S
    Stem Cells; 1994 May; 12(3):253-61. PubMed ID: 8075592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
    Neelis KJ; Dubbelman YD; Qingliang L; Thomas GR; Eaton DL; Wagemaker G
    Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro production of megakaryocytes from PIXY321 versus GM-CSF-mobilized peripheral blood progenitor cells.
    Lefebvre P; Winter JN; Rademaker AW; Goolsby C; Cohen I
    Stem Cells; 1997; 15(2):112-8. PubMed ID: 9090787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bryostatin 1 acts synergistically with interleukin-1 alpha to induce secretion of G-CSF and other cytokines from marrow stromal cells.
    Lilly M; Vo K; Le T; Takahashi G
    Exp Hematol; 1996 Apr; 24(5):613-21. PubMed ID: 8605966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-7 enhances the expression of IL-3 and granulocyte-macrophage-CSF mRNA in activated human T cells by post-transcriptional mechanisms.
    Dokter WH; Sierdsema SJ; Esselink MT; Halie MR; Vellenga E
    J Immunol; 1993 Apr; 150(7):2584-90. PubMed ID: 8454845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.
    Janowska-Wieczorek A; Marquez LA; Nabholtz JM; Cabuhat ML; Montaño J; Chang H; Rozmus J; Russell JA; Edwards DR; Turner AR
    Blood; 1999 May; 93(10):3379-90. PubMed ID: 10233890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell lines.
    Thalmeier K; Meissner P; Reisbach G; Hültner L; Mortensen BT; Brechtel A; Oostendorp RA; Dörmer P
    Exp Hematol; 1996 Jan; 24(1):1-10. PubMed ID: 8536785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell factor and PIXY-321 in acute lymphoblastic leukemia: in vitro study on proliferative effects and apoptosis.
    Petrucci MT; De Felice L; Ricciardi MR; Ariola C; Mascolo MG; Fenu S; Tafuri A
    Cytokines Mol Ther; 1996 Dec; 2(4):225-30. PubMed ID: 9384708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
    Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z
    Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of primary murine stroma induced by macrophage colony-stimulating factor.
    Yamada M; Suzu S; Akaiwa E; Wakimoto N; Hatake K; Motoyoshi K; Shimamura S
    J Cell Physiol; 1997 Oct; 173(1):1-9. PubMed ID: 9326443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The hematopoietic growth factor GM-CSF in chemotherapy for advanced breast carcinoma].
    Hoekman K; Wagstaff J; Boven E; van Groeningen CJ; Vermorken JB; Pinedo HM
    Ned Tijdschr Geneeskd; 1991 Mar; 135(10):415-9. PubMed ID: 2020313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressive effects of recombinant human monokine induced by IFN-gamma (rHuMig) chemokine on the number of committed and primitive hemopoietic progenitors in liquid cultures of CD34+ human bone marrow cells.
    Schwartz GN; Liao F; Gress RE; Farber JM
    J Immunol; 1997 Jul; 159(2):895-904. PubMed ID: 9218609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis.
    Peters BG; Adkins DR; Harrison BR; Velasquez WS; Dunphy FR; Petruska PJ; Bowers CE; Niemeyer R; McIntyre W; Vrahnos D; Auberry SE; Spitzer G
    Bone Marrow Transplant; 1996 Jul; 18(1):93-102. PubMed ID: 8832001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of Fluorouracil-inducible GM-CSF gene therapy regulated by Egr-1 promoter on chemotherapeutic hematopoietic damage of tumor-bearing mice].
    Du N; Pei XT; Xiao WH; Sun JZ; Fu Y; Zhao H; Wang XL
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1281-6. PubMed ID: 19595187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.